Tenon Medical (TNON) Director Robert Weigle Receives 10,732 Shares

What Happened

• Robert K. Weigle, a director of Tenon Medical, converted 10,732 restricted stock units (RSUs) into 10,732 shares of common stock on July 31, 2026. The conversion is reported as an exercise/conversion of a derivative with an exercise price of $0.00, resulting in receipt of the shares without cash payment. The filing shows the derivative ceased (disposed) as part of the conversion; no sale of the newly issued shares is reported.

Key Details

• Transaction date: July 31, 2026
• Report filed: August 4, 2026 (timely)
• Instrument/Code: Reported as derivative exercise/conversion (code M)
• Shares converted/received: 10,732 shares @ $0.00
• Footnote: These shares represent the conversion of 10,732 RSUs granted to Mr. Weigle on October 13, 2025; each RSU equals one contingent right to one share.
• Shares owned after transaction: Not specified in this filing
• No 10b5-1 plan, tax withholding, or sale of shares disclosed here

Context

• This was a conversion of previously granted RSUs into common stock (no cash payment). Such conversions are routine for vested equity awards and do not by themselves indicate a buy or sell decision. Because no immediate sale was reported, the director retained the issued shares (unless other transactions not shown here occurred).